Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Hot flush, Hypoaesthesia
Clinical narrative: I am experiencing PVC's; Dizziness; Shortness of breath; hot flashes; lack of appetite; Episodes of trigeminy; Tachycardia; fatigue; Joint pain; headache; arm numb; Tunnel vision; chest pain, chest pain came back , ongoing chest pain; back pain; diarrhea; 101.6 temperature with Tylenol; chills; severe body aches; feeling miserable; nauseous,almost threw up; This spontaneous case was reported by a consumer and describes the occurrence of TUNNEL VISION (Tunnel vision) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023C21A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Endometriosis since 05-Oct-2015, Asthma since 2013, Narcolepsy since 22-Aug-2018, Anxiety since 2018, Allergy to antibiotic (Clindamycin) since 2013, Drug allergy (Nuvigil) since 2013 and Caffeine allergy. Concomitant products included AMITRIPTYLINE for Anxiety, MONTELUKAST for Asthma, ETHINYLESTRADIOL, NORETHISTERONE ACETATE (LOESTRIN) for Endometriosis, GABAPENTINE from 22-Aug-2018 to an unknown date for Narcolepsy, BUSPIRONE, GABAPENTIN (NEURONTIN) and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced FEELING ABNORMAL (feeling miserable), DIARRHOEA (diarrhea), NAUSEA (nauseous,almost threw up), PYREXIA (101.6 temperature with Tylenol), CHILLS (chills) and MYALGIA (severe body aches). On 13-May-2021, the patient experienced BACK PAIN (back pain). On 14-May-2021 at 4:00 PM, the patient experienced CHEST PAIN (chest pain, chest pain came back , ongoing chest pain). On 28-May-2021 at 3:00 PM, the patient experienced TUNNEL VISION (Tunnel vision) (seriousness criterion medically significant). On 03-Jun-2021 at 7:00 PM, the patient experienced HYPOAESTHESIA (arm numb). On an unknown date, the patient experienced VENTRICULAR EXTRASYSTOLES (I am experiencing PVC's), DIZZINESS (Dizziness), DYSPNOEA (Shortness of breath), HOT FLUSH (hot flashes), DECREASED APPETITE (lack of appetite), EXTRASYSTOLES (Episodes of trigeminy), TACHYCARDIA (Tachycardia), FATIGUE (fatigue), ARTHRALGIA (Joint pain) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) from 10-May-2021 to 13-May-2021 for Fever, at an unspecified dose and frequency. On 13-May-2021, FEELING ABNORMAL (feeling miserable), DIARRHOEA (diarrhea), NAUSEA (nauseous,almost threw up), PYREXIA (101.6 temperature with Tylenol), CHILLS (chills) and MYALGIA (severe body aches) had resolved. At the time of the report, TUNNEL VISION (Tunnel vision), CHEST PAIN (chest pain, chest pain came back , ongoing chest pain) and HYPOAESTHESIA (arm numb) had not resolved and VENTRICULAR EXTRASYSTOLES (I am experiencing PVC's), BACK PAIN (back pain), DIZZINESS (Dizziness), DYSPNOEA (Shortness of breath), HOT FLUSH (hot flashes), DECREASED APPETITE (lack of appetite), EXTRASYSTOLES (Episodes of trigeminy), TACHYCARDIA (Tachycardia), FATIGUE (fatigue), ARTHRALGIA (Joint pain) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-May-2021, Body temperature: 101.6 degree Celsius (High) 101.6 temperature. On 10-May-2021, Pain assessment (1-10): 4 (abnormal) severity is 4 out of 10 pain.         Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-128856 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Significant follow up received - Patient demographics, medical history, lab data, concomitant medications added, vaccination facility details updated, new serious event added and case upgraded to serious and narrative updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.